Global Health Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, Global Health stock has a consensus rating of "Strong Buy" and an average price target of ₹1,419. The average 1-year stock price forecast is 12.11% higher than the current stock price, while the lowest is ₹1,210 (-4.41%) and the highest is ₹1,570 (+24.03%).

Price Target: ₹1,419 (+12.11%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	₹1,210	₹1,419	₹1,422	₹1,570
Change	-4.41%	+12.11%	+12.34%	+24.03%

* Price targets were last updated on May 19, 2026.

Analyst Ratings

The average analyst rating for Global Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	6	6	6	8	11	11
Buy	4	5	5	4	4	4
Hold	5	4	4	4	2	2
Sell	1	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	15	15	16	17	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Alok Dalal Jefferies	Jefferies	Buy Maintains ₹1,500	Buy	Maintains	₹1,500	+18.50%	May 19, 2026

Financial Forecast

Revenue This Year

51.66B

from 44.10B

17.13%

from 44.10B

Revenue Next Year

59.35B

from 51.66B

14.90%

from 51.66B

EPS This Year

25.89

from 20.69

25.16%

from 20.69

EPS Next Year

32.27

from 25.89

24.63%

from 25.89

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	21.72B	27.10B	32.75B	36.92B	44.10B	51.66B
Revenue Growth	49.63%	24.74%	20.86%	12.74%	19.44%	17.13%
Gross Profit	10.06B	13.75B	17.17B	19.15B	23.17B	39.83B
Gross Margin	46.30%	50.76%	52.42%	51.87%	52.54%	77.11%
Operating Income	3.35B	4.84B	6.28B	6.83B	6.97B	9.17B
Net Income	1.96B	3.26B	4.78B	4.81B	5.56B	6.89B
EPS	-	-	-	-	20.69	25.89
EPS Growth	-	-	-	-	7.19%	25.16%
Forward PE	-	39.58	59.16	52.37	39.25	48.88
Dividend / Share	-	-	-	0.50	0.50	2.09
Dividend Growth	-	-	-	-	-	318.50%
Free Cash Flow	-418.52M	2.93B	2.21B	129.77M	-2.14B	3.34B
No. Analysts	-	-	-	-	-	17

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	55.8B
Avg	51.7B
Low	49.0B

Revenue Growth

Revenue Growth	2027	2028	2029
High	26.6%
Avg	17.1%
Low	11.0%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	25.89
Low	-

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	25.2%
Low	-